Notice of Change to PAR-12-032 (R01) and PAR-12-033 (R21)


Notice Number: NOT-OD-12-037

Key Dates

Release Date: February 14, 2012

Issued by

National Institutes of Health (NIH)
Office of Research on Women’s Health (ORWH)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Center for Complementary and Alternative Medicine (NCCAM)
Office of Behavioral and Social Sciences Research (OBSSR)
Office of Dietary Supplements (ODS)

Purpose

The purpose of this notice is to inform applicants of the contact information for the Letter of Intent for PAR-12-032 (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment (R01) and PAR-12-033(Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment (R21)).

Current language related to Letter of Intent within Section IV. 2. Content and Form of Application Submission:

None.

New language related to Letter of Intent within Section IV. 2. Content and Form of Application Submission:

Letter of Intent

Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:

Descriptive title of proposed research

Name, address, and telephone number of the PD(s)/PI(s)

Names of other key personnel

Participating institutions

Number and title of this funding opportunity

The letter of intent should be sent to:

Susan E. Maier, Ph.D.
Office of Research on Women’s Health (ORWH)
Democracy II, Suite 400
6707 Democracy Blvd
Bethesda, MD 20892-5484
Telephone: 301-435-1573
Fax: 301-402-1798
Email: Susan.Maier@nih.gov

Inquiries

Please direct all inquiries to:

Susan E. Maier, Ph.D.
Office of Research on Women’s Health (ORWH)
Democracy II, Suite 400
6707 Democracy Blvd
Bethesda, MD 20892-5484
Telephone: 301-435-1573
Fax: 301-402-1798
Email: Susan.Maier@nih.gov